PayPal Holdings, Inc. vs Viatris Inc — how do they compare? PayPal Holdings, Inc. trades at $52.25 (market cap $45.49B), while Viatris Inc trades at $16.45 (market cap $19.09B). The key difference: PayPal Holdings, Inc. is far larger — about 2.4× Viatris Inc's market cap, and Viatris Inc pays the higher dividend (2.89%). Which is the better fit depends on your goals.
| PYPL | VTRS | |
|---|---|---|
Market Cap | $45.49B | $19.09B |
Sector | Financials | Health |
52-Week High | $76.13 | $17.86 |
52-Week Low | $39.08 | $9.49 |
Enterprise Value | $47.64B | $31.21B |
Dividend Yield | 1.05% | 2.89% |
Signals from Pluang's Aura AI — not financial advice
PayPal (PYPL) trades at $53.18, down 3.24% on the day, reflecting recent volatility amid takeover speculation collapse and restructuring efforts. The stock shows bearish technical signals with key support at $51, while fundamentals remain solid with a P/E of 10.05, net income margin of 14.36%, and consistent revenue growth to $33.17B in 2025. Recent news highlights a strategic shift under new CEO Enrique Lores, targeting $1.5B in savings and expanding beyond branded checkout.
The outlook is mixed; valuation appears attractive with a consensus price target of $59.61, but near-term risks include execution of the turnaround plan and competitive pressures. Investor sentiment is cautious with 60% analyst hold ratings, though strong cash flow and dividend initiation provide stability. Upside depends on successful cost savings and new growth initiatives offsetting market skepticism.
Viatris (VTRS) trades at $16.61, down 1.6% over the past 24 hours. The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company reported a net loss of $3.51 billion in 2025 despite revenue of $14.30 billion, though recent quarters have shown earnings beats. Positive cash flow generation and a dividend payment highlight financial stability, while analyst sentiment is mixed with a majority hold rating.
The outlook for VTRS hinges on its ability to return to profitability and sustain operational improvements. Investment opportunities include strong cash flow, deleveraging progress, and pipeline developments, but risks involve persistent net losses, competitive pressures, and potential regulatory impacts from proposed generic drug tariffs.
Trailing returns across standard periods
Latest headlines on both assets
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →